Monday, February 3, 2020 12:21 AM
PALO ALTO, Calif.—PARC
, a Xerox company, announced last week that it has reached an agreement with global eyecare company Alcon
to develop innovative new treatments for eyecare. The agreement includes a licensing arrangement with Alcon to leverage PARC intellectual property for potential new products that are anticipated to enter the market over the next two to four years, according to the announcement. “Alcon has been working with PARC for more than three years to develop innovative technology that can be used with our vision care products,” Andy Pawson, president of Alcon’s Global Vision Care franchise, said.
Friday, January 17, 2020 12:18 AM
(NYSE: AGN), a global pharmaceutical company with more than 70 years of heritage in eyecare, announced a partnership with Von Miller, a former Super Bowl MVP, Denver Broncos linebacker and advocate for healthy vision, to shine a light on the millions of people living with glaucoma. As an ambassador for the “My Glaucoma”
campaign, Miller will address the misunderstandings and impact of glaucoma and encourage those with the disease, and their caregivers, to take early action, according to the announcement this week. This includes going to the doctor regularly and taking medications as prescribed.
Tuesday, January 14, 2020 12:15 AM
, an early stage biotechnology company based here, said Monday that it has entered into a strategic collaboration agreement with Janssen Pharmaceuticals Inc.
, a unit of Johnson & Johnson, that will work toward developing an eye drop treatment for retinal vascular diseases, such as Age-Related Macular Degeneration (AMD) and Diabetic Macular Oedema (DMO). The effort will focus on using mRNA targeted therapies. The agreement was facilitated by Johnson & Johnson Innovation. Exonate has developed small molecules that inhibit the production of pro-angiogenic vascular endothelial growth factor (VEGF) through the selective inhibition of serine/threonine-protein kinase (SRPK1)-mediated VEGF splicing, according to the announcement.
Wednesday, January 8, 2020 12:15 AM
PLEASANTON, Calif.—Samsung Electronics Co.
, a leader in digital vision technologies and maker of the world's first smart, wearable vision-assistive device, announced a strategic partnership to roll out IrisVision's groundbreaking technology worldwide. IrisVision's vision correction software platform utilizes the power of Samsung's industry leading Galaxy smartphones and XR devices and mobile AI platform to enable people with impaired vision to see clearly and live more independent lives, according to the announcement on Tuesday.
Thursday, December 19, 2019 12:15 AM
, a leading national managed eye health and vision plan group, announced that it has designated December as Gift of Sight Month. The vision care company noted that it had decided to establish the “holiday” after a Vision Wellness Study found that just 51 percent of people saw an eye doctor regularly. The same study also noted that 39 percent of consumers cited cost and/or affordability as the reason why household members do not see an eye doctor as often as they would like to.
Thursday, December 12, 2019 12:15 AM
MANASSAS, Va.—Notal Vision Inc.
, a privately held ophthalmic diagnostic services company focused on advancing eyecare with precision medicine, said this week that Ganot Capital
is extending a recent funding round to $25 million. The continued investment will enable Notal Vision to support the commercial growth of the company’s current service, ForeseeHome AMD Monitoring Program, as well as further research and development efforts for pipeline technologies, according to the announcement. “Pursuing additional funding has allowed us to expand our ForeseeHome field-based sales team,” chief executive officer Kester Nahen said in the announcement. “We have a proven model that includes low-cost medical devices, an effective artificial intelligence (AI)-driven decision support solution, and a dependable clinical patient engagement platform. With the additional investment, we believe we will be able to prove that partnering with accounts as an extension of their practice will drive deeper adoption of our home diagnostic services.”
Friday, July 20, 2018 12:15 AM
FARMINGTON, Conn. and MIDDLETOWN, Pa.—Horizon Technology Finance Corp.
(NASDAQ: HRZN), a leading specialty finance company, has led a $10 million loan facility for MacuLogix Inc.,
according to an announcement earlier this week. Horizon, based in Farmington, typically provides capital in the form of secured loans to venture capital backed companies in the technology, life science and health care information and services sectors. MacuLogix, a medical device company, manufactures the AdaptDx automated dark adaptometer, a device that allows eyecare professionals to measure retinal function to accurately diagnose age-related macular degeneration (AMD). AMD is the leading cause of irreversible blindness in adults, according to the announcement.
Wednesday, May 23, 2018 12:15 AM
has received a $300,000 gift from The Sunderland Foundation
, a group that supports construction projects undertaken by nonprofits in Kansas City and other Midwest markets.
Friday, December 22, 2017 12:24 AM
DANBURY, Conn.—Eschenbach Optik of America
has appointed Taron Sutcliffe, currently CFO of the company, as vice president and officer of the Corporation.
Wednesday, November 29, 2017 12:21 AM
ALISO VIEJO, Calif.—RxSight Inc.
reported this week that the FDA
has approved its Light Adjustable Lens and the Light Delivery Device (LDD) for treating certain patients post-cataract surgery.
Wednesday, October 4, 2017 12:18 AM
NEW YORK—Lighthouse Guild
celebrated its move to a new location and unveiled a new logo at a ribbon-cutting ceremony on Sept. 28.
Friday, September 1, 2017 12:27 AM
, a global nonprofit organization sponsored and founded by Luxottica, is teaming up with the nonprofit technology firm, everydayhero
, to launch its first global fitness and fundraising challenge.
Friday, July 14, 2017 12:18 AM
has received a $5,000 grant from the Monsanto Fund’s
2017 site grant initiative.
Wednesday, January 25, 2017 12:23 AM
NEW BRUNSWICK, N.J.—Johnson & Johnson
(NYSE: JNJ) reported Tuesday that its worldwide sales totaled $71.9 billion in fiscal 2016, an increase of 2.6 percent compared to 2015, and its adjusted earnings per share (EPS) totaled $6.73, an increase of 8.5 percent.